Feladilimab( —— )

Catalog No. M36892 CAS No. 2252518-85-5

Feladilimab (GSK3359609) is an IgG4 monoclonal antibody that is an ICOS agonist.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	375	Get Quote
5MG	615	Get Quote
10MG	938	Get Quote
25MG	1408	Get Quote
50MG	1822	Get Quote
100MG	2502	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Feladilimab
Note

Research use only, not for human use.
Brief Description

Feladilimab (GSK3359609) is an IgG4 monoclonal antibody that is an ICOS agonist.
Description

Feladilimab (Anti-ICOS/CD278 Reference Antibody (feladilimab); GSK3359609) is humanized IgG4 anti-ICOS agonist monoclonal antibody. Feladilimab binds to ICOS-expressing T cells. Feladilimab has the potential for the research of cancer.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Chromatin/Epigenetic
Target

COX
Recptor

COX | PD-1/PD-L1
Research Area

——
Indication

——

Chemical Information

CAS Number

2252518-85-5
Formula Weight
Molecular Formula

——
Purity

>98% (HPLC)
Solubility

——
SMILES

——
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Offidani M, et al. Belantamab Mafodotin for the Treatment of Multiple Myeloma: An Overview of the Clinical Efficacy and Safety. Drug Des Devel Ther. 2021 Jun 2;15:2401-2415.?

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

Product			Quantity Required*
Name *			E-mail Address *
Organization *			Phone Number
Remarks